– USA, IN – Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Kathy Turner and Craig Wallace to its Board as new independent directors, effective immediately, expanding the Board to 14 members.
“We are pleased to have reached an agreement with Ancora on a constructive path forward, and we look forward to working with Kathy and Craig toward our common goal of progressing our robust and innovative pipeline and driving near- and long-term sustainable growth and value for our shareholders.” said Board Chairman, David Hoover.
Kathy Turner and Craig Wallace also joined the Finance, Strategy, and Oversight Committee.
About Kathy Turner
Kathy Turner brings significant global experience in both the animal health and broader healthcare industries. She has held senior leadership positions at IDEXX Laboratories, including most recently as CMO, and served in various roles of increasing responsibility at Abbott Laboratories.
Kathy Turner held senior leadership positions in international commercial operations at IDEXX Laboratories, a global pet healthcare innovation company, from 2014 to 2023, including most recently serving as CMO. She brings a deep understanding of veterinary clinic operations through her tenure with IDEXX. In her nearly 30-year tenure at Abbott Laboratories, a multinational medical devices and healthcare company, she held multiple leadership positions, most recently leading commercial operations for Europe. She is currently on the Board of Veterinarians Without Borders, an organization that promotes animal well-being, human health, and economic development domestically and internationally.
About Craig Wallace
Craig Wallace is a well-respected animal health leader with more than 30 years of executive experience at companies such as Fort Dodge Animal Health, Trupanion, and Ceva.
Craig Wallace is President of C.S. Wallace Investments & Strategy, LLC, an animal health and human healthcare investment firm. Mr. Wallace previously served as CEO (North America/Pacific) of Ceva Santé Animale, the fifth-largest animal health company worldwide. He also held leadership roles at Trupanion, Inc., a pet insurance provider, and Fort Dodge Animal Health, a global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Additionally, he served on various boards of directors including the National Commission on Veterinary Economic Issues and the Kansas City Animal Health Corridor Advisory Board. He currently serves on the Board of Directors of 1C, a pet retail distributor, and KeraVet Bio, a veterinary wound care company.
About Elanco
Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life, and our Elanco Healthy Purpose™ Sustainability Initiatives – all to advance the health of animals, people, the planet, and our enterprise.
SOURCE: www.elanco.com.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
